Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)

BME:ROVI Revenue

Laboratorios Farmaceuticos Rovi had revenue of 191.67M EUR in the quarter ending June 30, 2026, with 20.02% growth. This brings the company's revenue in the last twelve months to 773.05M, up 3.21% year-over-year. In the year 2025, Laboratorios Farmaceuticos Rovi had annual revenue of 743.48M, down -2.65%.

• Revenue (ttm): 773.05M
• Revenue Growth: +3.21%
• P/S Ratio: 3.88
• Revenue / Employee: 312.98K
• Employees: 2,470
• Market Cap: 3.00B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	743.48M	-20.27M	-2.65%
Dec 31, 2024	763.75M	-65.76M	-7.93%
Dec 31, 2023	829.51M	11.81M	1.44%
Dec 31, 2022	817.70M	169.02M	26.06%
Dec 31, 2021	648.68M	228.72M	54.46%
Dec 31, 2020	419.96M	38.65M	10.14%
Dec 31, 2019	381.31M	78.11M	25.76%
Dec 31, 2018	303.20M	27.55M	10.00%
Dec 31, 2017	275.65M	10.48M	3.95%
Dec 31, 2016	265.17M	19.16M	7.79%
Dec 31, 2015	246.01M	7.96M	3.34%
Dec 31, 2014	238.05M	20.46M	9.40%
Dec 31, 2013	217.59M	15.66M	7.76%
Dec 31, 2012	201.92M	42.25M	26.46%
Dec 31, 2011	159.68M	1.03M	0.65%
Dec 31, 2010	158.65M	55.81M	54.28%
Dec 31, 2006	102.83M	22.48M	27.97%
Dec 31, 2005	80.36M	-	-

Data Source: Fiscal.ai Last updated: Jul 22, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 3, 2026

Data Sources Report a data error